HM Insurance Group (HM) raises nearly $40,000 through sharing the emotional 65 Roses® story and selling roses at their national sales conference.
Site Search
CARSTAR was recognized as a National Corporate Champion and was presented the Rising Star Award at the 16th annual Volunteer Leadership Conference in San Diego.
For the second year, Mastercard® becomes the Greater New York Chapter's top corporate sponsor thanks to two senior-level executives personally affected by cystic fibrosis who initially connected employees to the mission of the Cystic Fibrosis Foundation.
Choate Construction's 9th annual Cars & 'Q for the Cause raised over $435,400 for the Cystic Fibrosis Foundation, serving as a role model for corporations looking to integrate philanthropy into their business model.
Every person has two copies of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. A person must inherit two copies of the CFTR gene that contain mutations — one copy from each parent — to have cystic fibrosis.
In an international research project, scientists are examining cystic fibrosis transmembrane conductance regulator (CFTR) mutations to determine which ones cause CF and to provide additional information associated with these mutations. Their findings are available in an online searchable database.
Carrier (or genetic) testing not only plays a key role in the diagnosis of cystic fibrosis, but testing also allows parents to find out what their chances are of having a child with CF to help inform important family planning decisions.
Newborn screening (NBS) is a program run by each state to identify babies born with certain health conditions, including cystic fibrosis. Although a sweat test should ultimately be done to rule out or confirm a CF diagnosis, NBS can help you and your health care providers take immediate steps to keep your child as healthy as possible.
Dr. Dorothy Andersen first wrote about cystic fibrosis in 1938, and our understanding of the disease has significantly evolved since. There are still many misconceptions about what CF looks like today, from the person who lives with the disease to how it manifests.